Please login to the form below

Not currently logged in
Email:
Password:

Philip Payne completes Concept Life Sciences’ leadership team

He joins as chief commercial officer

Philip PayneIntegrated drug discovery and analytical company, Concept Life Sciences has appointed Philip Payne as its chief commercial officer, completing the group’s leadership line up.

Payne will work with Concept’s executive team and board to drive the group’s commercial strategy, leading the business development function and helping to guide the next stage of the company’s growth.

He will manage the sales team, including identification of new service areas, geographies and markets, supporting the broadening of Concept’s reach into Europe and the US.

He said: “I am excited to join Concept at this pivotal stage in the growth of the company, and look forward to working with the team to meet the group’s commercial and strategic objectives.”

Following 27 years’ experience Payne’s expertise lies in managing business integration development and pharma and biotech analytical and development services.

He joins from Aptuit, where he held various roles including vice president of sales and was responsible for the global business development team and strategic accounts.

Prior to this, he was business development director Europe and Asia for Sterile Technologies at Catalent Pharma Solutions.

Michael Fort, executive chairman, Concept Life Sciences, said: “Philip’s experience in managing multidisciplinary, international teams across a range of industries will be a great asset as Concept’s rapid rate of expansion continues.

“We are delighted to welcome Philip to the group.”

31st October 2017

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics